Total submissions: 17
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic Laboratories, |
RCV001579626 | SCV007309215 | benign | not specified | 2023-04-17 | criteria provided, single submitter | clinical testing | |
| Breakthrough Genomics, |
RCV001706511 | SCV005292127 | benign | not provided | criteria provided, single submitter | not provided | ||
| Dept Of Ophthalmology, |
RCV003888748 | SCV004705068 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
| Labcorp Genetics |
RCV000310340 | SCV000636530 | benign | Bardet-Biedl syndrome | 2026-02-04 | criteria provided, single submitter | clinical testing | |
| Illumina Laboratory Services, |
RCV001094337 | SCV000398063 | benign | Bardet-Biedl syndrome 2 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
| Dr. |
RCV005894497 | SCV006859417 | not provided | Malignant tumor of esophagus | no classification provided | in vitro | ||
| Dr. |
RCV005894498 | SCV006859416 | not provided | Gastric cancer | no classification provided | in vitro | ||
| Dr. |
RCV005894498 | SCV006859415 | not provided | Gastric cancer | no classification provided | in vitro | ||
| Dr. |
RCV005894498 | SCV006859414 | not provided | Gastric cancer | no classification provided | in vitro | ||
| Dr. |
RCV005894498 | SCV006859413 | not provided | Gastric cancer | no classification provided | in vitro | ||
| Dr. |
RCV005894499 | SCV006859412 | not provided | Ovarian serous cystadenocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005894499 | SCV006859411 | not provided | Ovarian serous cystadenocarcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005894496 | SCV006859410 | not provided | Hepatocellular carcinoma | no classification provided | in vitro | ||
| Dr. |
RCV005894496 | SCV006859409 | not provided | Hepatocellular carcinoma | no classification provided | in vitro | ||
| Genome Diagnostics Laboratory, |
RCV001706511 | SCV001932786 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
| Genome Diagnostics Laboratory, |
RCV001579626 | SCV001807934 | benign | not specified | no assertion criteria provided | clinical testing | ||
| Natera, |
RCV001094337 | SCV001457439 | benign | Bardet-Biedl syndrome 2 | 2020-09-16 | no assertion criteria provided | clinical testing |